News
News Center
Great news! Jiuzhitang Maker has been honored with the title of "Zhongguancun Golden Seed Enterprise."
2020-01-23
On January 14, 2020, the Zhongguancun Science Park Administrative Committee announced the ninth batch of the Golden Seed Enterprise list, and Jiuzhitang Maker was proudly recognized as one of the companies selected!
This time, a total of 223 "Golden Seed" enterprises were selected, representing industries such as energy conservation & environmental protection, healthcare, artificial intelligence, and smart equipment. As a member of the healthcare sector, Jiuzhitang Maker successfully advanced through the initial screening and roadshow evaluations, ultimately earning the prestigious title of "Zhongguancun Golden Seed Enterprise."
Quick Science Fact
"The Golden Seed Project" is an initiative tailored to the unique characteristics of early-stage companies. By carefully selecting "Golden Seed Enterprises," strengthening support services, and fostering a nurturing environment, the project aims to accelerate the growth of these startups. The Golden Seed Project also regularly releases the list of "Golden Seed Enterprises."
"Golden Seed Enterprises" refers to startups in strategic emerging industries that demonstrate strong growth potential in areas such as technological expertise, business models, innovation capabilities, entrepreneurial teams, and governance structures. The Golden Seed Program will provide these selected enterprises with specialized services, including startup mentoring and training, networking and collaboration opportunities, guidance on space expansion and site selection, as well as project promotion and access to financing.
Since its establishment just over two years ago, Jiuzhitang Maker has been rapidly advancing, achieving remarkable milestones. The company’s scalable stem cell production platform project—selected as one of Daxing District’s ten key initiatives—has been recommended for inclusion as a priority project under Beijing’s high-end, sophisticated, and cutting-edge industries. Additionally, the company has been recognized twice as a "Zhongguancun High-Tech Enterprise" and later as a "National High-Tech Enterprise." Moreover, its first-ever clinical trial application for a new stem-cell-based drug has already been accepted by regulatory authorities. Meanwhile, construction of the company’s Daxing production facility has been completed, and Jiuzhitang Maker has successfully moved in.
With a series of supportive policies rolled out one after another by multiple relevant national ministries and local governments—ranging from clinical research to industrial development—the industry is now benefiting from a thriving new landscape, while also witnessing fresh opportunities for the translation and commercialization of innovative stem-cell technologies and products. Jiuzhitang Maker will "ride the waves," ramping up its R&D efforts, expanding its market presence, and contributing meaningfully to the ambitious "Healthy China 2030" initiative.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy